| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | EP0652943B1 Hematopoietic facilitatory cells and their uses |
| 07/02/2008 | CN101210244A Neutrokine-alpha and Neutrokine-alpha splice variants |
| 07/02/2008 | CN101210049A Immunosuppressant-anti-CD25 mosaic monoclonal antibody |
| 07/02/2008 | CN101210044A Polypeptide and application thereof |
| 07/02/2008 | CN101209272A Panax ginseng super powder effervescent tablets and preparation thereof |
| 07/02/2008 | CN101209258A Immunopotentiator and antiviral composition for animal |
| 07/02/2008 | CN101209103A Health preserving soup |
| 07/02/2008 | CN101209088A Microorganism polyzyme additive agent for improving pigling growth and development |
| 07/02/2008 | CN101209086A Mineral substance type salt for dairy cattle and manufacturing method thereof |
| 07/02/2008 | CN101209085A Feed capable of reducing body fat and mortality rate of chicken and breeding method therewith |
| 07/02/2008 | CN101209083A High-saccharide energy feed and manufacturing method thereof |
| 07/02/2008 | CN100398650C Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application |
| 07/02/2008 | CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398152C Novel human beta 2 integrin alpha subunit |
| 07/02/2008 | CN100398114C Composition of stachyose and bee product |
| 07/02/2008 | CN100398113C Nano selenium of Melatonin and its preparation method |
| 07/02/2008 | CN100398010C Donkey-hide gelatine paste and its preparing method |
| 07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393854 Respiratory system disorders; asthma |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393831 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393630 Immunological adjuvants and antigen entrapment; combining a submicron oil-in-water emulsion with a selected antigen entrapped in, or adsorbed to, a biodegradable microparticle, wherein the microparticle is formed from a poly(L-lactide), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) |
| 07/01/2008 | US7393542 administering a food, chewing gum or drink containing a treated product of peanut seed coats, to a patient suffering from allergies |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 07/01/2008 | US7393523 Peptides for active anti-cytokine immunization |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076321A1 Engineered anti-tslp antibody |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008075949A1 Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms |
| 06/26/2008 | WO2008075685A1 IgA PRODUCTION PROMOTER |
| 06/26/2008 | WO2008075621A1 Antacid |
| 06/26/2008 | WO2008075349A1 Therapeutic methods using a thymus peptide |
| 06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | WO2008075038A1 Binding agents to the integrin alpha-11 subunit |
| 06/26/2008 | WO2008075028A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008074975A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008074966A1 Crth2 antagonists |
| 06/26/2008 | WO2008074821A1 Indole derivatives as s1p1 receptor agonists |
| 06/26/2008 | WO2008074820A1 Oxadiazole derivatives as s1p1 receptor agonists |
| 06/26/2008 | WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | WO2008074130A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1 |
| 06/26/2008 | WO2008050363A3 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 06/26/2008 | WO2008043782A3 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 06/26/2008 | WO2007075605A3 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
| 06/26/2008 | WO2007073175A3 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 06/26/2008 | US20080154199 Treating an allergic emergency by automatically injecting a first dose of epinephrine and, optionally subsequently, manually injecting a second dose from the same device; both doses have a volume of 0.3 mL of 1 mg epinephrine/ mL of solution; antianaphylactic agents; suitable for children (>12yrs); kits |
| 06/26/2008 | US20080153917 Sigma Receptor Ligands |
| 06/26/2008 | US20080153882 Pharmaceutical Composition Comprising Ppar Regulator |
| 06/26/2008 | US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity |
| 06/26/2008 | US20080153855 Chemical Compounds |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators |
| 06/26/2008 | US20080153797 Identifying compounds that can treat autoimmune conditions; ulcerative colitis, inflammatory bowel disease, Crohn's disease, psoriasis, actinic keratosis, arthritis, multiple sclerosis, optic neuritis |
| 06/26/2008 | US20080153792 Drug Identification and Treatment Method |
| 06/26/2008 | US20080153774 4' -C-substituted-2-haloadenosine derivative |
| 06/26/2008 | US20080153744 Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080152738 Oil-in-water emulsions; agglutination; evaporation; lectin |
| 06/26/2008 | US20080152671 Novel vaccination |
| 06/26/2008 | US20080152668 Thymosin Alpha 1 Peptide/Polymer Conjugates |
| 06/26/2008 | US20080152666 Apoptosis-inducing polypeptides |
| 06/26/2008 | US20080152664 Increasing oocyte fertilization via enhancing sperm-oocyte binding, fusion or activation |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | DE102006061186A1 Use of a compound containing aluminum and chlorine is used to prepare a pharmaceutical or cosmetic composition for treating skin disorders associated with inflammation, irritation or swelling |
| 06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | CA2698307A1 Histophilus somni antigens, compositions and methods of use |
| 06/26/2008 | CA2673592A1 Methods for the treatment of il-1.beta. related diseases |
| 06/26/2008 | CA2673468A1 Indole derivatives as s1p1 receptor agonists |
| 06/26/2008 | CA2673356A1 Crth2 antagonists |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2673235A1 Agents for promoting iga production |
| 06/26/2008 | CA2673214A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2672976A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2672784A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1 |
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/26/2008 | CA2671538A1 Engineered anti-tslp antibody |
| 06/26/2008 | CA2671525A1 Indolylmaleimide derivatives |
| 06/25/2008 | EP1935978A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 06/25/2008 | EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1934259A2 Nanobodies and polypeptides against egfr and igf-ir |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933839A1 Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance |
| 06/25/2008 | EP1933832A2 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| 06/25/2008 | EP1933828A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 06/25/2008 | EP1846441B1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 06/25/2008 | EP1560834B1 New tricyclic derivatives as ltd4 antagonists |
| 06/25/2008 | EP1463755B1 Recombinant polypeptides |